FDA
-
-
-
-
-
-
-
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®
-
-
-
-
-
-
-
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meet
-
-
-
-
-
-
-
Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Tonix publishes TONMYA pharmacokinetics study in peer-reviewed journal
-
-
-
-
-
-
-
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
-
335,175 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


